EnWave's proprietary Radiant Energy Vacuum ("REV") technology combines microwave energy with vacuum pressure to produce high-speed dehydration of live or active pharmaceuticals in vials. The Company has developed two versions of REV for use in drying live or active pharmaceuticals: bioREV(TM), a dehydration method for materials which require a gentler drying process without extreme temperature changes or freezing, and freezeREV, a dehydration method for frozen material where low moisture levels in the final product are imperative for long product shelf-life.

"The Saskatchewan Research Council currently performs pilot-scale vaccine production for a number of vaccine producers in Canada, and they are keen to find a dehydration alternative that is faster and less expensive than freeze drying," said Dr. Tim Durance, EnWave's Chairman & Co-CEO. "Our prototype freezeREV technology is designed to dry material in minutes, compared to days required for conventional freeze dryers. It will significantly reduce processing costs.

While the technology worked well for recent samples of antibodies, we are looking forward to testing the machine on a new vaccine in order to further prove the concept of freezeREV. Additionally, we are saving the company many hundreds of thousands of dollars by eliminating the need to build a laboratory, capable of handling pathogenic material, and instantly acquiring access to the highly-trained scientists and engineers at the SRC."

"SRC is dedicated to providing research, development and demonstration solutions that address current industry needs," said Dale Kelly, vice-president of SRC's Agriculture, Biotechnology and Food Division. "We are excited to work with EnWave on piloting Radiant Energy Vacuum technology to evaluate its potential as an alternative to current processing and preservation methods of freeze drying for vaccines and biologics."

About SRC

SRC is Saskatchewan's leading provider of applied R&D and technology commercialization. It takes the leading-edge knowledge developed in Saskatchewan and sells it to the world and, at the same time, brings the best knowledge the world has to offer and applies it to the unique Saskatchewan situations.

SRC was established in 1947 to advance the development of the province in the physical sciences. Today, the company has evolved to become a market-driven corporation, selling services and products to companies in Saskatchewan and around the world. The corporation has more than 340 staff. Annual revenues are about $41 million and growing. More information is available about the SRC at http://www.src.sk.ca/.

About EnWave

Using proprietary technologies developed in conjunction with the University of British Columbia, EnWave is focused on the development of new methods of dehydrating food and biological materials using Radiant Energy Vacuum technology under its nutraREVTM, powderREV, bioREVTM and freezeREV brands. REV technology combines microwave energy transfer under vacuum to dehydrate and alter structures and drive chemical reactions, thereby creating unique product characteristics for both food products and medical applications that include fruit, vegetables, probiotics, enzymes, proteins, food cultures, vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Dr. Tim Durance, Chairman & Co-CEO

This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions: there is no guarantee that the Company's REV technology can or will improve dehydration processes in the target industries; even if the Company's REV technology can be used as described in this document, there is no guarantee that such use will result in orders for the Company's REV technology.

The TSX Venture Exchange has neither approved nor disapproved the information contained herein.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:
EnWave Corporation
Dr. Tim Durance
Chairman & Co-CEO
(604) 822-4425
tdurance@enwave.net

EnWave Corporation
Jennifer Thompson
V.P. Corporate Development & Investor Relations
(604) 603-6549
jthompson@enwave.net
www.enwave.net

SOURCE: EnWave Corporation

mailto:tdurance@enwave.net
mailto:jthompson@enwave.net
http://www.enwave.net

EnWave's proprietary Radiant Energy Vacuum ("REV") technology combines microwave energy with vacuum pressure to produce high-speed dehydration of live or active pharmaceuticals in vials. The Company has developed two versions of REV for use in drying live or active pharmaceuticals: bioREV(TM), a dehydration method for materials which require a gentler drying process without extreme temperature changes or freezing, and freezeREV, a dehydration method for frozen material where low moisture levels in the final product are imperative for long product shelf-life.

"The Saskatchewan Research Council currently performs pilot-scale vaccine production for a number of vaccine producers in Canada, and they are keen to find a dehydration alternative that is faster and less expensive than freeze drying," said Dr. Tim Durance, EnWave's Chairman & Co-CEO. "Our prototype freezeREV technology is designed to dry material in minutes, compared to days required for conventional freeze dryers. It will significantly reduce processing costs.

While the technology worked well for recent samples of antibodies, we are looking forward to testing the machine on a new vaccine in order to further prove the concept of freezeREV. Additionally, we are saving the company many hundreds of thousands of dollars by eliminating the need to build a laboratory, capable of handling pathogenic material, and instantly acquiring access to the highly-trained scientists and engineers at the SRC."

"SRC is dedicated to providing research, development and demonstration solutions that address current industry needs," said Dale Kelly, vice-president of SRC's Agriculture, Biotechnology and Food Division. "We are excited to work with EnWave on piloting Radiant Energy Vacuum technology to evaluate its potential as an alternative to current processing and preservation methods of freeze drying for vaccines and biologics."

About SRC

SRC is Saskatchewan's leading provider of applied R&D and technology commercialization. It takes the leading-edge knowledge developed in Saskatchewan and sells it to the world and, at the same time, brings the best knowledge the world has to offer and applies it to the unique Saskatchewan situations.

SRC was established in 1947 to advance the development of the province in the physical sciences. Today, the company has evolved to become a market-driven corporation, selling services and products to companies in Saskatchewan and around the world. The corporation has more than 340 staff. Annual revenues are about $41 million and growing. More information is available about the SRC at http://www.src.sk.ca/.

About EnWave

Using proprietary technologies developed in conjunction with the University of British Columbia, EnWave is focused on the development of new methods of dehydrating food and biological materials using Radiant Energy Vacuum technology under its nutraREVTM, powderREV, bioREVTM and freezeREV brands. REV technology combines microwave energy transfer under vacuum to dehydrate and alter structures and drive chemical reactions, thereby creating unique product characteristics for both food products and medical applications that include fruit, vegetables, probiotics, enzymes, proteins, food cultures, vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Dr. Tim Durance, Chairman & Co-CEO

This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions: there is no guarantee that the Company's REV technology can or will improve dehydration processes in the target industries; even if the Company's REV technology can be used as described in this document, there is no guarantee that such use will result in orders for the Company's REV technology.

SOURCE: EnWave Corporation

EnWave Corporation
Dr. Tim Durance
Chairman & Co-CEO
(604) 822-4425
tdurance@enwave.net
EnWave Corporation
Jennifer Thompson
V.P. Corporate Development & Investor Relations
(604) 603-6549
jthompson@enwave.net
www.enwave.net

Under the terms of the agreement, EnWave will pay SectorSpeak a monthly retainer fee of $3,000 for its services for a period of 12 months. EnWave will also grant SectorSpeak an option to purchase 200,000 common shares of the company at the price of $0.50 per common share for a period of five years based on the terms and conditions of the Company's stock option plan, and subject to exchange approval.

SectorSpeak Principal, Mr. Hogan Mullally, will maintain an arms-length relationship with EnWave. Neither Mr. Mullally, nor SectorSpeak, currently holds any shares of EnWave.

About EnWave

Using proprietary technologies developed in conjunction with the University of British Columbia, EnWave is focused on the development of new methods of dehydrating food and biological materials using Radiant Energy Vacuum technology under its nutraREVTM, powderREV, bioREVTM and freezeREV brands. REV technology combines microwave energy transfer under vacuum to dehydrate and alter structures and drive chemical reactions, thereby creating unique product characteristics for both food products and medical applications that include fruit, vegetables, probiotics, enzymes, proteins, food cultures, vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation

John McNicol, President & Co-CEO

This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions: there is no guarantee that the Company's REV technology can or will improve dehydration processes in the target industries; even if the Company's REV technology can be used as described in this document, there is no guarantee that such use will result in orders for the Company's REV technology.

The TSX Venture Exchange has neither approved nor disapproved the information contained herein. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:
EnWave Corporation
John McNicol
President & Co-CEO
(604) 601-8524
john.mcnicol@enwave.net

EnWave Corporation
Jennifer Thompson
V.P. Corporate Development & Investor Relations
(604) 603-6549
jthompson@enwave.net
www.enwave.net

SOURCE: EnWave Corporation

mailto:john.mcnicol@enwave.net
mailto:jthompson@enwave.net
http://www.enwave.net

The Natural Sciences and Engineering Research Council ("NSERC") has awarded Dr. Tim Durance, EnWave's Chairman & Co-CEO, $190,000 payable over 5 years to continue his work at the University of British Columbia on Radiant Energy Vacuum technology for drying and stabilizing vaccines, probiotic bacteria, and natural antimicrobial agents. This technology is designed to produce room temperature stable vaccines and antibodies at a fraction of the cost and processing time over freeze drying which, when proven commercially, would be a considerable breakthrough over that technology.

NRC-IRAP is providing EnWave with over $175,000 in matching funds over two years to continue the development of EnWave's powderREV bulk powder dehydration technology. powderREV is being designed to provide high-speed dehydration of live or active organisms at significantly reduced cost than the current industry standard of freeze drying. This is the second major contribution received by EnWave from the NRC-IRAP program in less than five years.

EnWave was also selected by the B.C. Innovation Council - Commercialization of Agricultural Technology Competition ("BCIC CAT Competition") to receive a $10,000 grant to develop a business plan for the Company's next version of the nutraREV(TM) food dehydration technology. Companies selected for grants are also eligible to compete for additional technology commercialization grants of up to $250,000 for their proposed technologies. Companies must submit business plans by October 31, 2009 and the plans chosen by the BCIC will receive the second stage of grants in Q4 2009.

About NSERC

NSERC aims to make Canada a country of discoverers and innovators for the benefit of all Canadians. The agency supports university students in their advanced studies, promotes and supports discovery research, and fosters innovation by encouraging Canadian companies to participate and invest in postsecondary research projects. NSERC researchers are on the vanguard of science, building on Canada's long tradition of scientific excellence. More information about NSERC is available at www.nserc-crsng.gc.ca.

About NRC-IRAP

NRC-IRAP provides a range of both technical and business-oriented advisory services along with potential financial support to qualified innovative Canadian small- and medium-sized enterprises. Financial assistance for this project is a direct result of the Government of Canada's Economic Action Plan. More information about NRC-IRAP is available at www.irap-pari.nrc.gc.ca.

About BC Innovation Council

The British Columbia Innovation Council (BCIC) is the lead organization charged with driving the commercialization of innovation in British Columbia. BCIC is focused on accelerating the growth of our science and technology communities and competitively positioning British Columbia in the global science and technology economy in order to provide significant employment opportunities and a high standard of living for British Columbians. BCIC is a Crown agency of the Province of British Columbia. More information is available about BCIC at www.bcic.ca.

About EnWave

EnWave Corporation is focused on commercializing new methods for dehydrating food and biological materials using Radiant Energy Vacuum technology under its nutraREV(TM), powderREV, bioREV(TM) and freezeREV brands. Radiant Energy Vacuum technology uses microwave energy transfer under vacuum to dehydrate and alter structures and drive chemical reactions required for the dehydration of food and biological products including fruit, vegetables, probiotics, enzymes, proteins, food cultures, vaccines and antibodies. Radiant Energy Vacuum technology was developed in conjunction with the University of British Columbia. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Dr. Tim Durance, Chairman & Co-CEO

This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions: there is no guarantee that the Company's REV technology can or will improve dehydration processes in the target industries; even if the Company's REV technology can be used as described in this document, there is no guarantee that such use will result in orders for the Company's REV technology.

SOURCE: EnWave Corporation

EnWave Corporation
Dr. Tim Durance
Chairman & Co-CEO
(604) 822-4425
tdurance@enwave.net
EnWave Corporation
Jennifer Thompson
V.P. Corporate Development & Investor Relations
(604) 603-6549
jthompson@enwave.net
www.enwave.net